Analyst Ratings for Cardiff Oncology (CRDF)
CRDF Rating Summary
CRDF Price Target Summary
- Highest: $19.00 (Ladenburg Thalmann)
- Lowest: $3.50 (Jefferies)
- Average: $10.10
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.10 (+437.2%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$10.10 (+437.2%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2026 | Noble Capital | Robert LeBoyer | New Coverage | Outperform (N/A) |
12.00 (N/A) |
2.66 (1.88) |
-29.32% | Details |
| 7/8/2025 | Ladenburg Thalmann | Kevin DeGeeter | New Coverage | Buy (N/A) |
19.00 (N/A) |
3.65 (1.88) |
-48.49% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
